September 12, 2018
The Offering will consist of up to 8,000,000 units (“Units”) at a purchase price of $0.25 per Unit, for aggregate gross proceeds of up to $2,000,000. Each Unit will consist of one common share in the capital of the Company (“Common Share”) and one common share purchase warrant (“Warrant”). Each Warrant will entitle the holder to purchase one Common Share for a period of five years from the date of issuance, at a purchase price of $0.30. The company may pay a 5% cash finders fee. The proceeds from the Offering will be used for working capital and general corporate purposes.
ON BEHALF OF THE BOARD
Lotus Ventures Inc. “Dale McClanaghan” Dale McClanaghan, President and CEO
For further information: Dale McClanaghan: dalemcclanaghan@gmail.com (604) 644-9844
Forward-Looking Information
This news release contains certain “forward-looking information” within the meaning of applicable Canadian
securities law. Forward-looking information is frequently characterized by words such as “plan”, “continue”,
“expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and
other similar words, or information that certain events or conditions “may” or “will” occur. This information
is only a prediction. Various assumptions were used in drawing the conclusions or making the projections
contained in the forward-looking information throughout this news release. Forward-looking information
includes, but is not limited to: receipt of regulatory approvals of the Offering, inability to complete the
Offering on the proposed terms or at all, delays in obtaining or inability to obtain required government or
other regulatory approvals, including licenses to cultivate cannabis, regulatory or political change,
competition and other risks affecting the Company in particular and the medical cannabis industry generally.
Forward-looking information is based on the opinions and estimates of management at the date the
information is made, and is subject to a variety of risks and uncertainties and other factors that could cause
actual events or results to differ materially from those projected in the forward-looking information. The
Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any
forward-looking information, whether as a result of new information, future events or otherwise, except as
expressly required by applicable law.
The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of
this release.